Kidney Disease Market Industry Share, Size, Growth, Demands, Revenue, Top Leaders and Application
The global kidney disease market is expected to witness significant growth during the forecast period. As per the reports of the CDC, it is expected that more than 37 million people in the U.S. suffer from CKD, whereas globally, more than 500 million people are affected. An increasing number of patients suffering from kidney failure is projected to drive the market.
Data Bridge Market Research analyses a growth rate in the global kidney disease market in the forecast period 2022-2029. The expected CAGR of the global kidney disease market tends to be around 5.50% in the mentioned forecast period. The market was valued at USD 96.72 billion in 2021, and it would grow up to USD 148.43 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Kidney disease damages the nephron, unable for the kidney to function to remove the waste product from the body. The disease can cause other severe problems such as hypertension, kidney failure, brain aneurysm, and chronic pain. Other symptoms include blood in urine, kidney stones, urinary tract or kidney infections, and back or side pain. It may develop over many years and lead to end-stage kidney (or renal) disease (ESRD). It has become a massive public health issue.
Key players operating in the global kidney disease market include:
Pfizer Inc (U.S.)
AstraZeneca (U.K.)
Bristol-Myers Squibb Company (U.S.)
Allergan,Inc (Ireland)
Dr. Reddy's Laboratories Ltd (India)
Endo International plc (Ireland)
Teva Pharmaceutical Industries Ltd (Israel)
Sun Pharmaceutical Industries Ltd (India)
Global Kidney Disease Market Dynamics
Drivers
Increased Incidence of Kidney Diseases
The rising incidence of chronic kidney disease globally is majorly responsible for boosting the growth of the global renal drugs market. According to the National Kidney Foundation records, nearly 10% of the global population is affected by chronic kidney disease (CKD). As per WHO facts 2019, about 1.13 billion people worldwide have hypertension. In 2014–2016, diabetes and hypertension were responsible for around 75% of kidney failure. Thus, it boosts market growth.
Browse a Detailed Summary of the Research Report @ https://www.databridgemarketre....search.com/reports/g
Technological Advancements
There have been many advances concerning diagnostic and treatment procedures that are boosting the market growth. For instance, in April 2020, FMCNA established the National Intensive Renal Care Reserve, which comprised devices that can deliver CRRT, IHD, and SLED/PIRRT. Any such conditions that cause reduced kidney function lead to chronic kidney disease (CKD), which may develop over a period and lead to end-stage renal kidney disease where the kidney can no longer function independently.
Opportunities
Increased Demands For Blood Tests
Among the major tests, the foremost test for the diagnosis of kidney disease includes a blood test, which helps understand how well the kidneys work. It measures levels of a waste product called creatinine in the blood. Furthermore, the demand for these tests is projected to increase as the incidence of CKD is high and growing in many parts of the world. The global incidence of end-stage renal disease (ESRD) is high and growing at a significant rate. Thus, it creates more opportunities for market growth.
Increasing Demand for Hospitals
The presence of a large number of hospitals in the U.S., combined with a well-developed healthcare infrastructure, is another factor contributing to market growth. For instance, as per the American Hospital Association, there were around 208 federal government hospitals, 6,090 community hospitals, and 625 nonfederal psychiatric hospitals in the U.S. Major increase in the number of hospital admissions for acute kidney disease is boosting the demand for dialysis as well as transplant, thereby boosting the market growth.
Browse More Reports:
Global Maternal Health Market https://www.databridgemarketre....search.com/reports/g
Global Clinical Trials Market https://www.databridgemarketre....search.com/reports/g
Global Dysphagia Market https://www.databridgemarketre....search.com/reports/g
Global Solid Tumors Market https://www.databridgemarketre....search.com/reports/g
Global Lice Treatment Market https://www.databridgemarketre....search.com/reports/g
Global Presbyopia Market https://www.databridgemarketre....search.com/reports/g
Global Physical Therapy Market https://www.databridgemarketre....search.com/reports/g
Global Medical Display Market https://www.databridgemarketre....search.com/reports/g
Global eHealth Market https://www.databridgemarketre....search.com/reports/g
U.A.E Aesthetics/Cosmetics Market https://www.databridgemarketre....search.com/reports/u
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decisionmaking process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: corporatesales@databridgemarketresearch.com
1 (877) 773-1002